An ear inspection device configured for being at least partially introduced into an external ear canal for determining an ear condition, such as temperature, in particular at the subject's eardrum, wherein the device comprises an infrared sensor unit configured for detecting infrared radiation from the ear, and an electronic imaging unit configured for capturing images based on radiation in the visible range from the ear, wherein the electronic imaging unit exhibits at least one optical axis arranged such that it can be radially offset within the ear canal, and wherein the infrared sensor unit exhibits a visual axis arranged such that it can be positioned centrically within the ear canal or radially offset within the same semicircle, especially the same quadrant, of the cross section of the ear canal.

A system, wearable device, and method include a light emitter configured to emit light at a first wavelength of between approximately 900 and 1000 nanometers and at a second wavelength of approximately 1350 nanometers, a first light detector spaced at a first distance from the light emitter, and a second light detector spaced at a second distance from the light emitter, the second distance approximately twice the first distance. At least one of hydration and glycogen of muscle tissue is determinable based on a relationship between backscatter light from the muscle tissue as detected by the second light detector and backscatter light from non-muscle tissue as detected by the first light detector.

A medical imaging device in accordance with the present application includes a color separation prism, a fluorescence image sensor, a visible light image sensor, and a bandpass filter. The color separation prism splits light into first light belonging to a visible light wavelength band and second light belonging to a fluorescence wavelength band. The fluorescence image sensor is provided at an output side of the color separation prism and is configured to image at least part of the second light belonging to the fluorescence wavelength band separated by the dichroic film. The visible light image sensor is provided at the output side of the color separation prism and is configured to image at least part of the first light belonging to the visible light wavelength band separated by the dichroic film. The bandpass filter is disposed between the color separation prism and the fluorescence image sensor.

An apparatus may include an ultrasonic sensor array, a light source system and a control system. Some implementations may include an ultrasonic transmitter. The control system may be operatively configured to control the light source system to emit light that induces acoustic wave emissions inside a target object. The control system may be operatively configured to select a first acquisition time delay for the reception of acoustic wave emissions primarily from a first depth inside the target object. The control system may be operatively configured to acquire first ultrasonic image data from the acoustic wave emissions received by the ultrasonic sensor array during a first acquisition time window. The first acquisition time window may be initiated at an end time of the first acquisition time delay.

An oximeter probe determines an oxygen saturation for the tissue and determines a quality value for the oxygen saturation and associated measurements of the tissue. The quality value is calculated from reflectance data received at the detectors of the oximeter probe. The oximeter probe then displays a value for the oxygen saturation with the error value to indicate a quality level for the oxygen saturation and associated values used to calculate oxygen saturation.

A subdermal imaging system which may determine whether a person's body is in contact with a display, and perform a subdermal imaging process to determine subdermal characteristics by a photoacoustic imaging process. Ultrasonic emissions emitted from the photoacoustic process may be received with an ultrasonic receiver array. The subdermal imaging system may adjust the wavelength and/or intensity of the photoacoustic process in order to image desired subdermal features.

A microfluidic system includes a flexible substrate having a skin-facing surface and a back-facing surface; a microfluidic network at least partially embedded in or supported by the flexible substrate; a sensor fluidically connected to the microfluidic network, wherein the microfluidic network is configured to transport a biofluid from a skin surface to the sensor; and a capping layer, having a capping layer skin-facing surface and a back-facing surface, wherein the back-facing surface of the capping layer is attached to the skin-facing surface of the substrate. The flexible substrate is at least partially formed of a thermoplastic elastomer or a polymer configured to provide a high barrier to vapor or liquid water transmission.

The invention relates to analyzing a substance. An optical medium is arrange on a substance surface with at least one region of the optical medium surface in contact with the substance surface. An excitation light beam is emitted through the contacting region of the medium surface to the substance surface. A measurement light beam is emitted through the optical medium to the contacting region of the medium surface such that the measurement light beam and the excitation light beam overlap on the interface of the optical medium and of the substance surface, on which the measurement light beam is reflected. A deflection of the reflected measurement light beam is detected in dependence on the wavelength of the excitation light beam. The substance is then analyzed based on the detected deflection of the measurement light beam in dependence on the wavelength of the excitation light beam.

A light pulse is emitted from a light source for illuminating a medium. Energy level data of the light pulse is measured before the light pulse enters the medium. An image sensor captures an image that includes an interference pattern generated by an exit signal of the light pulse exiting the medium interfering with a reference wavefront. Normalized intensity data is generated by normalizing intensity data exit signal data by the energy level data.

A sensor head is provided comprising a housing enclosing at least two light sources configured to deliver light to a patient and comprising a blue LED first light source that delivers light at an excitatory wavelength and a green LED second light source, and at least one light detector configured to detect light at an emission wavelength from the patient. The sensor is useful for non-invasive monitoring of fluorescent tracers agents.